Target Name: MIR4323
NCBI ID: G100422980
Review Report on MIR4323 Target / Biomarker Content of Review Report on MIR4323 Target / Biomarker
MIR4323
Other Name(s): hsa-miR-4323 | microRNA 4323 | hsa-mir-4323 | MicroRNA 4323

MIR4323: A Drug Target / Disease Biomarker

MIR4323 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the MIR family of RNA-binding proteins, which are known for their ability to interact with RNA molecules. One of the unique features of MIR4323 is its ability to form a stable complex with double-stranded RNA, which allows it to play a role in regulating gene expression.

MIR4323 has been shown to be involved in a variety of physiological processes in the body, including cell survival, growth, and division. It has also been shown to play a role in the development and progression of a variety of diseases, including cancer. This has led to MIR4323 as a drug target of interest.

One of the ways that MIR4323 is thought to work is by binding to specific RNA molecules and regulating their translation into proteins. This can lead to the translation of different proteins into the cell, which can have different effects on the cell. For example, MIR4323 has been shown to play a role in the regulation of the protein known as Bcl-2, which is known for its ability to prevent apoptosis, or cell death.

Another way that MIR4323 may be involved in the development of cancer is by promoting the growth and survival of cancer cells. MIR4323 has been shown to be involved in the regulation of cell proliferation, and has been shown to promote the growth of cancer cells in a variety of models. This has led to MIR4323 as a potential drug target for cancer.

MIR4323 has also been shown to be involved in the regulation of pain perception and neuroinflammation. This has led to MIR4323 as a potential drug target for treating neuroinflammation and pain.

MIR4323 has also been shown to play a role in the regulation of the immune system. This has led to MIR4323 as a potential drug target for treating autoimmune diseases.

MIR4323 has also been shown to play a role in the regulation of the blood-brain barrier. This has led to MIR4323 as a potential drug target for treating brain-related diseases.

MIR4323 has also been shown to play a role in the regulation of the nervous system. This has led to MIR4323 as a potential drug target for treating neurological diseases.

MIR4323 has also been shown to play a role in the regulation of the endocrine system. This has led to MIR4323 as a potential drug target for treating endocrine-related diseases.

MIR4323 has also been shown to play a role in the regulation of the cell cycle. This has led to MIR4323 as a potential drug target for treating cancer.

MIR4323 has also been shown to play a role in the regulation of the apoptosis-homeostasis cycle. This has led to MIR4323 as a potential drug target for treating apoptosis.

MIR4323 has also been shown to play a role in the regulation of the autophagy pathway. This has led to MIR4323 as a potential drug target for treating autophagy.

MIR4323 has also been shown to play a role in the regulation of the cell-mediated immunity pathway. This has led to MIR4323 as a potential drug target for treating cell-mediated immunity.

MIR4323 has also been shown to play a role in the regulation of the DNA damage response pathway. This has led to MIR4323 as a potential drug target for treating DNA damage.

MIR4323 has also been shown to play a role in the regulation of the cell growth and division pathway. This has led to MIR4323 as a potential drug target for treating cell growth and division.

MIR4323 has also been shown to play a role in the regulation of the angiogenesis pathway. This has led to MIR4323 as a potential drug target for treating angiogenesis.

MIR4323 has also been shown to play a role in the regulation of the inflammation-response pathway. This has led to MIR4323 as a potential drug target for treating inflammation.

MIR4323 has also been shown to play a role in the regulation of the fibrosis pathway. This has led to MIR4323 as a potential drug target for treating fibrosis.

MIR4323 has also been shown to play a role in the regulation of the cellular stress response pathway. This has led to MIR4323 as a potential drug target for treating cellular stress response.

MIR4323 has also been shown to play a role in the regulation of the DNA replication pathway. This has led to MIR4323 as a potential drug target for treating DNA replication.

MIR4323 has also been shown to play a role in the regulation of the transcription factor-mediated gene expression pathway. This has led to MIR4323 as a potential drug target for treating transcription factor-mediated gene expression.

MIR4323 has also been shown to play a role in the regulation of the RNA-protein interaction pathway. This has led to MIR4323 as a potential drug target for treating RNA-protein interaction.

MIR4323 has also been shown to play a role in the regulation of the post-transcriptional modification pathway. This has led to MIR4323 as a potential drug target for treating post-transcriptional modification.

MIR4323 has also been shown to play a role in the regulation of the protein-protein interaction pathway. This has led to MIR4323 as a potential drug target for treating protein-protein interaction.

MIR4323 has also been shown to play a role in the regulation of the intracellular signaling pathway. This has led to MIR4323 as a potential drug target for treating intracellular signaling pathway.

MIR4323 has also been shown to play a role in the regulation of the cytoskeletal structure and function pathway. This has led to MIR4323 as a potential drug target for treating cytoskeletal structure and function pathway.

MIR4323 has also been shown to play a role in the regulation of the cell-cell adhesion pathway. This has led to MIR4323 as a potential drug target for treating cell-cell adhesion pathway.

MIR4323 has also been shown to play a role in the regulation of the stem cell maintenance pathway. This has led to MIR4323 as a potential drug target for treating stem cell maintenance pathway.

MIR4323 has also been shown to play a role in the regulation of the tissue repair pathway. This has led to MIR4323 as a potential drug target for treating tissue repair pathway.

MIR4323 has also been shown to play a role in the regulation of the wound healing pathway. This has led to MIR4323 as a potential drug target for treating wound healing pathway.

MIR4323 has also been shown to play a role in the regulation of the skin penetration pathway. This has led to MIR4323 as a potential drug target for treating skin penetration pathway.

MIR4323 has also been shown to play a role in the regulation of the blood vessel formation pathway. This has led to MIR4323 as a potential drug target for treating blood vessel formation pathway.

MIR4323 has also been shown to play a role in the regulation of the tissue regeneration pathway. This has led to MIR4323 as a potential drug target for treating tissue regeneration pathway.

MIR4323 has also been shown to play a role in the regulation of the stem cell proliferation pathway. This has led to MIR4323 as a potential drug target for treating stem cell proliferation pathway.

MIR4323 has also been shown to play a role in the regulation of the neurogenesis pathway. This has led to MIR4323 as a potential drug target for treating neurogenesis pathway.

MIR4323 has also been shown to play a role in the regulation of the glial cell response pathway. This has led to MIR4323 as a potential drug target for treating glial cell response pathway.

MIR4323 has also been shown to play a role in the regulation of the pain perception pathway. This has led to MIR4323 as a potential drug target for treating pain perception pathway.

MIR4323 has also been shown to play a role in the regulation of the neuroendocrine pathway. This has led to MIR4323 as a potential drug target

Protein Name: MicroRNA 4323

The "MIR4323 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4323 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512